Onderzoeksoutput per jaar
Onderzoeksoutput per jaar
Onderzoeksoutput
- 10 resultaten
Zoekresultaten
-
2022
A phase I clinical trial on intracranial administration of autologous myeloid dendritic cells (myDC) in combination with ipilimumab and nivolumab in patients with recurrent glioblastoma (rGB)
Schwarze, J. K., Geens, W., Tijtgat, J., Awada, G., Vanbinst, A., Everaert, H., Seynaeve, L., Michotte, A., Bruneau, M., VAN RIET, I., Tuyaerts, S., Duerinck, J. & Neyns, B., 3 jun 2022.Onderzoeksoutput: Poster
-
-
2021
371P - Low-dose bevacizumab for the treatment of focal post-radiation necrosis of the brain
Tijtgat, J., Schwarze, J. K. & Awada, G., 16 sep 2021.Onderzoeksoutput: Poster
-
2020
A phase I clinical trial on intratumoral and intracavitary administration of ipilimumab and nivolumab in patients with recurrent glioblastoma: Brussel Poster presentation on Glitipni-study at ASCO Annual Meeting 2020; May 29 - June 2, 2020; virtual
Schwarze, J. K., Duerinck, J., Dufait, I., Awada, G., Klein, S., Fischbuch, L., Seynaeve, L., Vaeyens, F., Rogiers, A., Everaert, H., Vanbinst, A., Michotte, A. & Neyns, B., 2020.Onderzoeksoutput: Poster
-
High total metabolic tumor volume on 18F-FDG-PET/CT correlates with lack of immune response in advanced melanoma patients treated with pembrolizumab.
Gondry, O., Awada, G., Özdemir, I., Schwarze, J. K., Daeninck, E., Jansen, Y., Seremet, T., Goethals, L., Everaert, H., Neyns, B. & Keyaerts, M., 15 jan 2020, (Unpublished).Onderzoeksoutput: Poster
-
Interim safety and efficacy results of a phase II clinical trial on trametinib and low-dose dabrafenib in patients with advanced BRAFV600 wild-type melanoma
Awada, G., Schwarze, J. K., Reijmen, E., Goyvaerts, C., Fasolino, G., Aspeslagh, S. & Neyns, B., 2020.Onderzoeksoutput: Poster
Bestand32 Downloads (Pure) -
2019
A sequential dual cohort phase II clinical trial on adjuvant low-dose nivolumab with or without low-dose ipilimumab as adjuvant therapy following the resection of melanoma macrometastases (MM)
Schwarze, J. K., Vandersleyen, V., Awada, G., Seremet, T., Jansen, Y. & Neyns, B., 2019.Onderzoeksoutput: Poster
-
GLIAVAX: A stratified phase II clinical trial of avelumab and axitinib in patients with recurrent glioblastoma.
Neyns, B., Ben Salama, L., Awada, G., De Cremer, J., Schwarze, J. K., Seynaeve, L., Du Four, S., Fischbuch, L., Vanbinst, A-M., Everaert, H., Michotte, A., Rogiers, A. I., Theuns, P. & Duerinck, J., 2019.Onderzoeksoutput: Poster
-
2018
A phase I clinical trial on intratumoral administration of autologous CD1c (BDCA-1)+ myeloid dendritic cells (myDC) in combination with ipilimumab (IPI) and avelumab (AVE) plus intravenous low-dose nivolumab (NIVO) in patients with advanced solid tumors
Schwarze, J. K., Awada, G., Van Riet, I. & Neyns, B., 14 dec 2018.Onderzoeksoutput: Poster
-
Baseline total metabolic tumor volume assessed by 18FDG-PET/CT predicts outcome in advanced melanoma patients treated with pembrolizumab
Awada, G., Özdemir, I., Schwarze, J. K., Daeninck, E., Gondry, O., Jansen, Y., Caplanusi, T., Keyaerts, M., Everaert, H. & Neyns, B., 13 dec 2018.Onderzoeksoutput: Poster